about
Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agentsAssociation of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican PatientsNrf2-Mediated Regulation of Skeletal Muscle Glycogen MetabolismChronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult MiceThe induction of the transcription factor Nrf2 enhances the antinociceptive effects of delta-opioid receptors in diabetic mice.Discovery of an NRF1-specific inducer from a large-scale chemical library using a direct NRF1-protein monitoring system.Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair.Association between the NF-E2 Related Factor 2 Gene Polymorphism and Oxidative Stress, Anti-Oxidative Status, and Newly-Diagnosed Type 2 Diabetes Mellitus in a Chinese PopulationKeap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet.Cytoprotective mechanism of ferulic acid against high glucose-induced oxidative stress in cardiomyocytes and hepatocytes.SKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans.Novel Grb14-Mediated Cross Talk between Insulin and p62/Nrf2 Pathways Regulates Liver Lipogenesis and Selective Insulin Resistance.Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling.Genetic variants of nuclear factor erythroid-derived 2-like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast ChinaRole and Regulation of Glutathione Metabolism in Plasmodium falciparum.Redox regulation of proteasome function.High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway.The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus.Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy.Oxidative Stress and Metabolism: The NF-Erythroid 2 p45-Related Factor 2:Kelch-like ECH-Associated Protein 1 System and Regulatory T Lymphocytes in Ischemic AKI.Thrombospondin 1 protects pancreatic β-cells from lipotoxicity via the PERK-NRF2 pathway.Smooth muscle-generated methylglyoxal impairs endothelial cell-mediated vasodilatation of cerebral microvessels in type 1 diabetic rats.Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats.Activation of Nrf2 signaling by natural products-can it alleviate diabetes?Profiling of antioxidative enzyme expression induced by various food components using targeted proteome analysis.HX-1171 attenuates pancreatic β-cell apoptosis and hyperglycemia-mediated oxidative stress via Nrf2 activation in streptozotocin-induced diabetic model.Mitochondrial Stasis Reveals p62-Mediated Ubiquitination in Parkin-Independent Mitophagy and Mitigates Nonalcoholic Fatty Liver Disease
P2860
Q28085561-AB5B532A-98D4-41DD-8107-1FAF87A4053CQ28394464-7321154E-5B8C-4FBC-9CDF-DE38034E3CFEQ28829068-91E3DE46-F6B2-40C4-AC5E-FA5301464C63Q32186681-851C25AD-1CA7-4B4B-8532-04036D299605Q33897876-73D65E1D-BA40-45C4-A6C1-1386695C2D7CQ35622081-9C27DE77-376A-4C59-BE11-669811CFA056Q35764015-7F65063B-70C5-4716-8DAC-29F7500001F5Q35902662-BCDBCAC9-5E06-4F73-9FFA-B77E38C9958BQ36563849-B2ED359E-AE3F-4CBC-A57F-213979E7FB0BQ36574224-C7913705-D46D-4145-9487-C195EF9C2677Q36733239-72676C38-5471-40B5-9FEA-BFC8A3BCA6F0Q37141714-29EFBA1E-7DAF-4761-B69C-C27532D06F74Q37151577-B380398B-1A04-4E88-AE55-25AF7E413C7EQ37370799-8A324EA4-8551-49C9-8731-A0566FFBB0ABQ38523502-1C0B71AB-7648-4EEA-A07C-E6FDC97C3082Q39439087-F163B0E9-03FA-48B7-B612-C7D3706F5FBFQ40340196-4A093BC5-89BD-496E-89C5-DFDD1657CEDBQ41623135-6D8EFF04-638C-4A3E-9D65-0B6922B4E8C4Q42141815-EF66F7C0-5E97-47A8-A796-3539FD54BFA6Q43158047-7E54F34A-F951-427F-93C3-FB2EB523D382Q46371926-70DF7C8A-DEF5-44F4-8029-2F0640822C1FQ47096132-7E7D02B0-914E-4043-B221-535EBBFD2CEEQ47113147-25CB5A2E-EF27-4530-AC9A-90F1EC43DBC5Q49385295-90BABC1D-5789-4219-A1B9-87E28DF708D5Q51094132-5E36F486-B791-4F4C-9BD4-B93DA4CCF706Q55262468-20A58574-D78C-4073-8720-A2A8BFF913E8Q57044776-3F407C55-A608-496D-A7A8-2C46FCC9E7F5
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The Keap1-Nrf2 system and diabetes mellitus.
@en
type
label
The Keap1-Nrf2 system and diabetes mellitus.
@en
prefLabel
The Keap1-Nrf2 system and diabetes mellitus.
@en
P2093
P1476
The Keap1-Nrf2 system and diabetes mellitus.
@en
P2093
Akira Uruno
Masayuki Yamamoto
Yoko Yagishita
P356
10.1016/J.ABB.2014.12.012
P407
P577
2014-12-17T00:00:00Z